The Meridian Bioscience Market Focus

As access to healthcare continues to improve worldwide, the market for infectious disease tests continues to expand. Meridian's product development strategy is driven by three core concepts—speed, simplicity, and accuracy in the areas of C. difficile, H. pylori, foodborne diseases, respiratory infections, parasitology, and stool transports. William J. Motto, Executive Chairman of Meridian Bioscience, Inc., notes:

"In this market there is a continuing shift from conventional testing—which requires highly trained personnel and lengthy turnaround times—to more technologically advanced testing that can be performed by personnel with less training and completed in minutes or hours." Read Mr. Motto’s bio here

We maintain market leadership by responding to emerging diseases and changing medical needs. Since 1991, Meridian has developed and introduced more than 56 innovative products.

Meridian also grows through acquisition, licensing, or supply agreements that have added almost 100 new products to our catalog.

Rapid, accurate diagnostics can mean faster recovery, shorter hospital stays, and reduced expenses for the patient and the healthcare system.

Learn more about our subsidiaries

Meet the Meridian Board of Directors & Management